PACS Group Past Earnings Performance
Past criteria checks 6/6
PACS Group has been growing earnings at an average annual rate of 22.9%, while the Healthcare industry saw earnings growing at 2.7% annually. Revenues have been growing at an average rate of 22.2% per year. PACS Group's return on equity is 23.4%, and it has net margins of 4.5%.
Key information
22.89%
Earnings growth rate
16.07%
EPS growth rate
| Healthcare Industry Growth | 8.50% |
| Revenue growth rate | 22.15% |
| Return on equity | 23.39% |
| Net Margin | 4.49% |
| Last Earnings Update | 31 Mar 2026 |
Recent past performance updates
Recent updates
PACS: Q1 Execution And 2026 Outlook Will Drive Repricing Potential
Analysts have raised their average price target on PACS Group from about $35 to roughly $49.67, citing updated models following the company's recent Q1 results and refreshed 2026 guidance, along with what they describe as a strong quarter that has helped the stock regain traction with the Street. Analyst Commentary Recent research updates on PACS Group focus heavily on how the latest Q1 results and refreshed 2026 guidance feed into valuation, execution risk, and the stock's growth profile.PACS Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
PACS Group, Inc. ( NYSE:PACS ) investors will be delighted, with the company turning in some strong numbers with its...PACS Group: Strong Comeback That's Backed By Improving Fundamentals
Summary PACS Group is reaffirmed as a 'Buy' for long-term investors, following a 257% rebound from oversold lows. PACS demonstrates robust credit health with $795M liquidity, 0.1x net leverage, and strong interest coverage, supporting aggressive organic and acquisition-driven growth. Guidance for FY26 includes 8% revenue growth and 22% adjusted EBITDA growth, with margin expansion driven by facility maturation and industry consolidation opportunities. Despite a recent rally, PACS trades at a forward EV/EBITDA of 12.4 versus its peer NHC at 17.2, making it attractive on corrections. Read the full article on Seeking AlphaPACS Group: Under The Radar Healthcare Stock To Buy On Corrections
Summary PACS Group is a hidden gem stock with strong growth potential in the skilled nursing and assisted living facility industry. The company has shown aggressive growth through acquisitions, and as SNF facilities mature, growth is likely to remain healthy. Despite limited analyst coverage, PACS stock has shown an uptrend and is expected to outperform index and healthcare sector returns in the next three to five years. Read the full article on Seeking AlphaPACS Group: A Healthy Debut For This Acute Care Provider
Summary PACS Group shares rose 10% on the first day of trading after its IPO. The company operates 208 facilities across 9 states, providing post-acute care to 20,000 patients on a daily basis. Concerns about leverage, earnings power, and risks such as reimbursement policies and competition make investors cautious. Read the full article on Seeking AlphaRevenue & Expenses Breakdown
How PACS Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 5,432 | 244 | 468 | 0 |
| 31 Dec 25 | 5,289 | 192 | 454 | 0 |
| 30 Sep 25 | 5,139 | 169 | 427 | 0 |
| 30 Jun 25 | 4,821 | 132 | 393 | 0 |
| 31 Mar 25 | 4,447 | 49 | 427 | 0 |
| 31 Dec 24 | 4,090 | 56 | 375 | 0 |
| 30 Sep 24 | 3,735 | 53 | 328 | 0 |
| 30 Jun 24 | 3,498 | 57 | 307 | 0 |
| 31 Mar 24 | 3,323 | 110 | 231 | 0 |
| 31 Dec 23 | 3,111 | 113 | 240 | 0 |
| 31 Dec 22 | 2,422 | 150 | 170 | 0 |
| 31 Dec 21 | 1,167 | 48 | 106 | 0 |
Quality Earnings: PACS has high quality earnings.
Growing Profit Margin: PACS's current net profit margins (4.5%) are higher than last year (1.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PACS's earnings have grown significantly by 22.9% per year over the past 5 years.
Accelerating Growth: PACS's earnings growth over the past year (393.3%) exceeds its 5-year average (22.9% per year).
Earnings vs Industry: PACS earnings growth over the past year (393.3%) exceeded the Healthcare industry 16%.
Return on Equity
High ROE: PACS's Return on Equity (23.4%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/29 11:42 |
| End of Day Share Price | 2026/06/26 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PACS Group, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Cassorla | Citigroup Inc |
| Lisa Gill | J.P. Morgan |
| Calvin Sternick | J.P. Morgan |